URL details: talzennahcp.com
URL title:
Home Page | TALZENNA® (talazoparib) HCP Site | Safety Info
URL description:
See risks and benefits of TALZENNA® (talazoparib), a once-daily oral PARP inhibitor for treating gBRCAm HER2- locally advanced or metastatic breast cancer.
URL last crawled:
2022-12-21
URL speed:
0.279 MB/s,
downloaded in 0.400 seconds
We found no external links pointing to this url.